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 Abstract. 
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a rare 
cause of pulmonary hypertension in newborns. Maternally inherited point mutations in 
Forkhead Box F1 gene (FOXF1), deletions of the gene or its long-range enhancers on the 
maternal allele are responsible for this neonatal lethal disorder. Here we describe 
monozygotic twins and one full-term newborn with ACD and gastrointestinal malformations 
caused by de novo mutations of FOXF1 on the maternal inherited alleles. Since this parental 
transmission is consistent with genomic imprinting, the parent-of-origin specific monoallelic 
expression of genes, we have undertaken a detailed analysis of both allelic expression and 
DNA methylation. FOXF1 and its neighboring gene FENDRR were both biallelically 
expressed in a wide range of fetal tissues, including lung and intestine. Furthermore detailed 
methylation screening within the 16q24.1 regions failed to identify regions of allelic 
methylation, suggesting that disrupted imprinting is not responsible for ACDMPV. 
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 Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV; MIM# 
265380) is a rare lethal lung disorder caused by persistent pulmonary hypertension (Alameh 
et al. 2002) in which newborns subsequently die of hypoxemic respiratory failure. More than 
half of patients have associated congenital anomalies: the most frequent being 
gastrointestinal, genitourinary and cardiovascular malformations (Alameh et al. 2002; Al 
Hathol et al. 2000). Familial occurrence has been reported in 10% of patients, although the 
true incidence of this condition is unknown. Heterozygous mutations in the FOXF1 
transcription factor (Stankiewicz et al. 2009) or deletions of distant mesodermal enhancers, 
encompassing the long non-coding (lnc)RNAs LINC01081 and LINC01082, are present in 
most patients (Sen et al. 2013; Szafranski et al. 2013; Szafranski et al. 2014; Szafranski et al. 
2016a).  Interestingly deletions that remove FOXF1 gene also affect the neighboring 
transcript FENDRR (previously known as FOXF1-AS1) a ncRNA transcribed from the 
opposite DNA strand (Grote and Hermann, 2013). Intriguingly when samples are informative 
~90% of FOXF1 mutations are maternally derived (Sen et al. 2013; Leiden Open Variation 
Database, LOVD). Furthermore, ~95% of reported pathogenic deletions involving the 
upstream regulatory region are de novo on the maternal allele, consistent with this locus 
being subject to genomic imprinting (Szafranski et al. 2016a; Decipher database). However 
to date, no imprinted transcripts have been identified at this locus. 
 Genomic imprinting involves the marking of the genes during gametogenesis to 
achieve monoallelic, parent-of-origin expression. Allele-specific methylation of DNA, as 
well as chromatin structure and histone modifications, is also involved in this process in 
somatic cells (reviewed in Monk, 2015). Many imprinted genes are organized in clusters with 
monoallelic expression resulting from the sharing of cis-regulating features such as 
differentially methylated regions (DMRs). Genetic aberrations encompassing imprinted loci 
are associated with several of the known imprinting disorders, which have helped 
characterize the mechanisms leading to these rare diseases. For example uniparental disomies 
(UPDs) or reciprocal deletions of 15q11.2-13 result in two clinically distinct 
neurobehavioural disorders, Prader-Willi syndrome (PWS) and Angelman syndrome 
(AS)(Malcolm et al. 1991; Nicholls et al. 1989). The anticipated mechanisms leading to 
ACDMPV are proposed to be similar to those resulting in AS, with mutations in an imprinted 
protein coding gene or deletions of long-range regulatory elements (Buiting et al. 1999).  
 Here we describe two monozygotic twins and a third case corresponding to a full-term 
newborn diagnosed with ACD associated with abdominal malformations and mutations of 
FOXF1 on the maternal allele (see supporting information for full clinical details). In the first 
two cases antenatal ultrasound at 20 weeks gestation of a healthy 30 years old mother’s first 
pregnancy showed an abdominal cystic mass in monochorionic diamniotic twins. There was 
history of consanguinity in the parents, but no neonatal deaths in the family reported. Female 
twins were born at 36 weeks of gestational age. The first twin (I.1) had a birth weight of 
2280g (27th centile). At 24 hours of age, she developed respiratory distress with pulmonary 
hypertension. On day 5 severe coagulopathy with a grade three intraventricular hemorrhage 
was observed by cerebral ultrasound. Extracorporeal membrane oxygenation (ECMO) 
treatment was not considered because of the poor prognosis, and the patient died soon after. 
The anatomopathology of the lung confirmed the diagnosis of ACD (Supp. Fig S1). Partial 
annular pancreas and colonic stenosis were present at autopsy; the rest of the examination 
was unremarkable.  
 The second twin (I.2) had a birth weight of 2180g (19th centile) with abdominal X-
ray revealing dilated bowel loops. On day 2 of life she developed severe hypoxemia, with 
episodes of bradycardia and hypotension, requiring progressively increasing ventilatory and 
inotropic support with no response despite treatment with inhaled nitric oxide (iNO). On the 
4th day of life she was admitted to neonatal intensive care due to severe pulmonary 
hypertension, thus ECMO was initiated. On 7th day of life, the sister’s pathology report 
confirmed ACD, so a lung biopsy was performed. This also showed features of ACD. In the 
light of the poor prognosis associated with ACD, ECMO was withdrawn and the infant died. 
The autopsy confirmed ACD, with partial annular pancreas and colonic stenosis.  
 The third ACD patient was a full-term male neonate and was the first pregnancy of a 
healthy 32 years old female who has subsequently had an unaffected daughter. During the 
second trimester polyhydramnios was detected, raising the suspicion of a congenital 
abdominal malformation. Delivery occurred by cesarian-section at 38 weeks gestation with a 
birth weight of 2900g (24th centile). Ultrasound and radiologic studies showed bowel 
obstruction. He was taken to theatres at 8 hours of life where an annular pancreas, duodenal 
stenosis and intestinal malrotation were found. The second day of life, the oxygen 
requirements increased, with clinical signs of severe pulmonary hypertension refractory to 
escalating ventilatory and hemodynamic support as well as iNO. After 72 hours of life the 
patient presented a progressive respiratory deterioration with increasing oxygenation index 
and was cannulated for veno-venous ECMO. Within the following 5 days there was no 
decrease in pulmonary hypertension and ACD was suspected. A pulmonary biopsy was 
performed that showed histologic features of ACD. Given the poor prognosis of the disease, 
the decision was made to withdraw care and the patient died. All clinical and genetic details 
of these cases have been submitted to Leiden Open Variation Database (www.lovd.nl/). 
 To determine whether mutations in FOXF1 were responsable for these cases we 
performed genetic analysis by PCR and Sanger sequencing (see supporting information for 
materials and methods). This identified a heterozygous nonsense mutation c.810G>A in 
RefSeq transcript NM_001451.2 (p.W270*) in the twin cases with no evidence of the 
mutation in the parental samples consistent with the mutation arising de novo. Interestingly, 
this is a recurrent heterozygous mutation in ACDMPV and has previous been observed by 
Sen and colleagues (Sen et al. 2013). To ascertain whether the mutation was on the maternal 
chromosome we performed genotype analysis of single nucleotide polymorphisms (SNPs) 
within the FOXF1 region. This revealed that SNP rs2078304:C>G within intron 1 was 
informative, being heterozygous in the cases 1 and 2 but homozygous in the mother. Cloning 
of long-range PCR products incorporating both the mutation and SNP in the amplicon 
revealed that the mutation was on the maternal allele (Figure 1A, B). Similar mutation 
screening of FOXF1 in case 3 detected a de novo heterozygous one base pair deletion 
(c.105delG) (p.A36*). Using a similar strategy as described above, we identified that the 
polymorphism rs6145927: -/GGAGGGCTGCCT was informative, revealing that the 
mutation had also arisen on the maternal allele (Figure 1C). 
 To better understand the molecular mechanisms associated with this disease, we 
determined the allelic expression of FOXF1 in fetal and adult tissues and fully characterized 
the methylation profile throughout the 16q24.1 interval. To assess if FOXF1 and the 
neighboring transcript FENDRR are subject to genomic imprinting, we identified transcribed 
SNPs that would allow for allelic discrimination.  Imprinting analysis was performed in fetal 
and adult lung, intestine and term placenta samples since qRT-PCR revealed these were the 
most abundant for FOXF1 (Figure 1D; Supp. Fig S2; Supp. Table S1). Allele-specific RT-
PCR followed by Sanger sequencing revealed that both genes are biallelically expressed in 
multiple fetal tissues (Figure 1E, G) and adult lung biopsies (Supp. Fig S2), with results 
quantified by pyrosequencing (Figure 1F, H). Unfortunately no heterozygous SNPs were 
identified in our tissue cohort for the lncRNAs, LINC01081 and LINC01082.  
 Imprinted domains are associated with regions of allelic methylation inherited from 
the germline (Court et al. 2014) which is stable in somatic tissues irrespective of the 
expression levels making it an ideal epigenetic signature for screening novel imprinted loci. 
Since CpG island promoters associated with imprinted transcripts are often differentially 
methylated we performed allelic bisulphite PCR on the bidirectional promoter interval 
associated with FOXF1 and FENDRR.  We observe that this region is robustly unmethylated 
in all tissues analyzed (Figure 2; Supp. Fig S3). In an attempt to identify novel imprinted 
DMRs we performed a bioinformatic screen of methyl-seq datasets from tissues associated 
with the ACD phenotype. We identified various non-overlapping, single-copy regions in 
lung, pancreas and intestine with partial methylation profiles consistent with allelic 
methylation (for selection criteria see materials and methods section in the supporting 
information) (Figure 2A). However when assessing the methylation profiles of these regions 
in methyl-seq datasets from sperm, oocyte and pre-implantation embryos none were 
consistent with imprinting. Interestingly, ~250kb of the FOXF1-lncRNA interval is 
methylated in sperm and less methylated in oocyte, however this subject to pre-implantation 
reprograming being largely unmethylated in blastocysts (Figure 2B). 
 Using standard allelic bisulfite PCR, we assessed regions with partial methylation 
observed in at least two target tissues in more detail. In all candidate regions analyzed the 
methylation was mosaically present on both alleles in lung, intestine, pancreas and placenta-
derived DNA (Figure 2C; Supp. Fig S3). This includes 6 of the10 CpGs within the proposed 
DMRs (region 1 in Fig. 2C) mapping within the critical region (Szafranski et al. 2013; 
Szafranski et al. 2016b).  
 FOXF1 is a transcription factor expressed in the lung mesenchyme and is essential for 
normal development. Consistent with previous northern blot analysis (Pierrou et al. 1994), 
our qRT-PCR expression profiling revealed restricted FOXF1 expression pattern with highest 
expression in lung, intestine and pancreas, the target tissues for ACDMPV. Heterozygous 
point mutations in FOXF1 and heterozygous deletions encompassing the transcript or 
upstream enhancers (Szafranski et al. 2013) are the main causes of ACDMPV. Clinical 
diagnosis is confirmed by observing misalignment of the pulmonary veins in post-mortem 
lung biopsies (Janney et al. 1981) although many ACDMPV infants present with extra-
pulmonary anomalies, including defects in the gastrointestinal, cardiovacular and 
genitourinary systems. Consistent with our observations mutations in the coding sequence of 
FOXF1 are associated with ACD and intestinal malrotation (Stankiewicz et al. 2009), which 
are explained by the essential role of FOXF1 in the formation of the dorsal mesentery during 
fetal development. Stankiewicz et al. also described three cases that presented with ACD, 
annular pancreas and intestinal stenosis and derived from a mutation in FOXF1 (Stankiewicz 
et al. 2009) similar to the three cases we describe.  
 To date ~200 cases of ACDMPV have been reported in literature, with 52 listed in the 
LOVD database. The majority of these cases are associated with maternally acquired genetic 
aberrations (Sen et al. 2013; Dharmadhikari  et al. 2015; Szafranski et al. 2016a) suggesting 
genomic imprinting may be involved in this disorder. Maternal segregation of a missense 
FOXF1 mutations in a familial case of ACDMPV (Sen et al. 2013) also suggests that the 
gene could be maternally expressed. Allele-specific expression analysis for FOXF1 failed to 
identify evidence of maternal expression and detailed methylation screening did not find any 
evidence for allelic methylation, a key epigenetic feature associated with imprinted loci. This 
is despite previous reports of modest maternal methylation within the newly defined critical 
region defined by minimal deletion overlap (Szafranski et al. 2016b). However it must be 
noted that the methylation experiments performed by Szafranski and co-workers were not 
performed using SNPs and the methylation profile was inferred from patient samples 
carrying deletions.  Our results are consistent with numerous genome-wide methylation 
screens for DMRs in which no parent-of-origin methylation profiles were reported within the 
16q24.1 interval (Court et al. 2014; Sanchez-Delgado et al. 2016).  This lack of direct 
evidence for imprinting is supported by a familial case in which the FOXF1 mutation, a 
c.90_96del, was inherited from the father (Szafranski  et al. 2016a) and a individual case in 
which a c.C231A mutation was also paternally transmissed (Reiter et al. 2016). Furthermore 
a 4.1 kb de novo enhancer deletion also arose on the paternal allele (Szafranski  et al. 2016a). 
Additional evidence supporting a lack of imprinted expression of FOXF1 comes from the 
recent description of four cases of paternal uniparental disomy for chromosome 
(UPD(16)pat) none of which presented with features consistent with ACDMPV (Soehn et al. 
2016; Donovan et al. 2016). Similarly, no consistent imprinting phenotype has been reported 
for the reciprocial UPD16mat (Soehn et al. 2016; Donovan et al. 2016; Scheuvens et al. 
2016), despite conditional overexpression of Foxf1 having lethal lung hypoplasia and 
vascular defects in mice (Dharmadhikari et al. 2016). This strongly suggests that the FOXF1 
gene is highly dosage-sensitive but not imprinted as all imprinting syndromes associated with 
UPD have classical phenotypes (reviewed in Lapunzina and Monk, 2011).  
 It remains possible that the FOXF1 is maternally expressed in very restricted cells 
within the lung. Recent work using trangenic lacZ-reporter mice revealed that the 
evolutionarily conserved Foxf1long-range enhancers demonstrate tissue-specific activity in 
the proximal and distal pulmonary blood vessels (Seo et al. 2016), which may regulate allelic 
expression in these discrete cell populations. However it remains to be seen if non-canonical 
tissue-specific imprinting occurs at this locus or if other principals can explain the parent-of-
origin effects observed for ACDMPV. Gender effects on human mutations rates have 
previously been reported at non-imprinted loci and are associated with the differences in male 
and female gametogensesis. This gives rise to distinct mutational signatures in offspring with 
increased parental age (Goldmann et al. 2016). However there is no obvious association with 
mothers age that could explain the phenomenon observed for FOXF1 suggesting another, yet 
to be identified, mechanism is responsible. 
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Figure legends. 
Figure 1. Identifying maternal FOXF1 mutations and analysis of allelic expression. (A) 
Map of the FOXF1 gene showing the positions of the mutations and SNPs used to ascertain 
parental inheritance. (B) The c.810G>A mutation in case 1 is on the same DNA strand as the 
C allele of the heterozygous rs2078304 SNP, consistent with a de novo mutation on the 
maternal allele. (C) The parental origin of the c.105delG mutation in case 3 was determined 
using the heterozygous in/del polymorphisms rs6145927, which revealed that the mutation 
was on the del allele consistent with a de novo mutation on the maternal allele. The 
nucleotide numbering uses +1 as the A of the ATG translation initiation codon in the 
reference sequence, with the initiation codon as codon 1. (D) Quantitative RT-PCR showing 
the expression profile of FOXF1.  (E) Sequence traces of RT-PCR products for FOXF1 in 
fetal tissues samples heterozygous for SNPs rs7185244:C>T located in the 3’UTR and (G) 
rs43140:G>T in exon 3 of FENDRR. The numbers under the electropherograms (F, H) 
represent the quantified allelic expression by pyrosequencing. 
 
Figure 2. Methylation profiling of the FOXF1 interval on chromosome 16.  
(A) The methyl-seq data reveals several partially methylated domains in multiple target 
tissues and that the FOXF1/FENDRR promoter CpG island is devoid of methylation in all 
tissues. The commonly deleted enhancer interval and the region of minimal deletion overlap 
is highlighted in yellow. (B) The same ~ 350 kb interval in sperm, oocytes and blastocysts 
methyl-seq datasets. The vertical black lines in the methyl-seq tracks represent the mean 
methylation value for individual CpG dinucleotides. A green box highlights the position of 
the CpG islands and transcripts are highlighted in blue type. 
(C) Bisulphite PCR and subcloning was used for confirmation. Each circle represents a single 
CpG dinucleotide on a DNA strand. (•) Methylated cytosine, (o) unmethylated cytosine. Each 
row corresponds to an individual cloned sequence. If heterozygous for a SNP the genotype is 
indicated. For clarity only methylation profiles for lung and pancreas are shown.  
 
 
 
 
 
 
